Interferon-induced TRAIL-independent cell death in DNase II-/- embryos

European Journal of Immunology

Volumn 40, Issue 9, 2010, Pages 2590-2598

  Kitahara, Yusuke ^a,b   Kawane, Kohki ^a,d   Nagata, Shigekazu ^a,c  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Apoptosis; Gene expression; IFN; TRAIL

Indexed keywords

CASPASE; DEOXYRIBONUCLEASE; DEOXYRIBONUCLEASE II; INTERFERON; INTERFERON RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; CELL DEATH; CELL LINE; EMBRYO DEATH; EPITHELIUM CELL; GENE DELETION; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; MOUSE; PATHOLOGY; TRANSGENE;

ANIMALS; CASPASES; CELL DEATH; CELL LINE; EMBRYO LOSS; ENDODEOXYRIBONUCLEASES; EPITHELIAL CELLS; HUMANS; INTERFERON TYPE I; LIVER; MICE; MICE, KNOCKOUT; RECEPTORS, INTERFERON; SEQUENCE DELETION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSGENES;

EID: 77956495008     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040604     Document Type: Article

References (41)

1. Jacobson, M. D., Weil, M. and Raff, M. C., Programmed cell death in animal development. Cell 1997. 88: 347-354.
2. Vaux, D. L. and Korsmeyer, S. J., Cell death in development. Cell 1999. 96: 245-254.
3. Wyllie, A. H., Kerr, J. F. R. and Currie, A. R., Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980. 68: 251-306.
4. Enari, M., Sakahira, H., Yokoyama, H., Okawa, H., Iwamatsu, A. and Nagata, S., A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998. 391: 43-50.
5. Kawane, K., Fukuyama, H., Yoshida, H., Nagase, H., Ohsawa, Y., Uchiyama, Y., Iida, T. et al., Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 2003. 4: 138-144.
6. Chasis, J. A. and Mohandas, N., Erythroblastic islands: niches for erythropoiesis. Blood 2008. 112: 470-478.
7. Kawane, K., Fukuyama, H., Kondoh, G., Takeda, J., Ohsawa, Y., Uchiyama, Y. and Nagata, S., Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 2001. 292: 1546-1549.
8. Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H. and Nagata, S., Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 2005. 6: 49-56.
9. Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R. and Stark, G. R., Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 2007. 6: 975-990.
10. Gomez-Benito, M., Balsas, P., Carvajal-Vergara, X., Pandiella, A., Anel, A., Marzo, I. and Naval, J., Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin. Cell. Signal. 2007. 19: 844-854.
11. Baker, P., Pettitt, A., Slupsky, J., Chen, H., Glenn, M., Zuzel, M. and Cawley, J., Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion. Blood 2002. 100: 647-653.
12. Chen, Q., Gong, B., Mahmoud-Ahmed, A., Zhou, A., Hsi, E., Hussein, M. and Almasan, A., Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 2001. 98: 2183-2192.
13. Chawla-Sarkar, M., Leaman, D. and Borden, E., Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin. Cancer Res. 2001. 7: 1821-1831.
14. Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K. and Yagita, H., Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 1999. 189: 1451-1460.
15. Yanase, N., Hata, K., Shimo, K., Hayashida, M., Evers, B. and Mizuguchi, J., Requirement of c-Jun NH2-terminal kinase activation in interferonalpha- induced apoptosis through upregulation of tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells. Exp. Cell Res. 2005. 310: 10-21.
16. de Weerd, N. A., Samarajiwa, S. A. and Hertzog, P. J., Type I interferon receptors: biochemistry and biological functions. J. Biol. Chem. 2007. 282: 20053-20057.
17. Nagata, S., Apoptosis by death factor. Cell 1997. 88: 355-365.
18. Griffith, T., Chin, W., Jackson, G., Lynch, D. and Kubin, M., Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 1998. 161: 2833-2840.
19. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R. et al., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995. 3: 673-682.
20. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A. and Ashkenazi, A., Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996. 271: 12687-12690.
21. Secchiero, P., Melloni, E., Heikinheimo, M., Mannisto, S., Di Pietro, R., Iacone, A. and Zauli, G., TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 2004. 103: 517-522.
22. Pfeffer, L. M., Dinarello, C. A., Herberman, R. B., Williams, B. R., Borden, E. C., Bordens, R., Walter, M. R. et al., Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 1998. 58: 2489-2499.
23. Williams, B., Transcriptional regulation of interferon-stimulated genes. Eur. J. Biochem. 1991. 200: 1-11.
24. Pfeffer, L., Kim, J., Pfeffer, S., Carrigan, D., Baker, D., Wei, L. and Homayouni, R., Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression. J. Biol. Chem. 2004. 279: 31304-31311.
25. Du, Z., Wei, L., Murti, A., Pfeffer, S., Fan, M., Yang, C. and Pfeffer, L., Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J. Cell. Biochem. 2007. 102: 1087-1094.
26. Zhang, F. and Sriram, S., Identification and characterization of the interferon-beta-mediated p53 signal pathway in human peripheral blood mononuclear cells. Immunology 2009. 128: e905-e918.
27. Panaretakis, T., Hjortsberg, L., Tamm, K., Bjorklund, A., Joseph, B. and Grander, D., Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2- terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Mol. Biol. Cell 2008. 19: 41-50.
28. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S. et al., Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003. 424: 516-523.
29. Kirou, K., Vakkalanka, R., Butler, M. and Crow, M., Induction of Fas ligand-mediated apoptosis by interferon-alpha. Clin. Immunol. 2000. 95: 218-226.
30. Crowder, C., Dahle, Ø., Davis, R., Gabrielsen, O. and Rudikoff, S., PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction. Blood 2005. 105: 1280-1287.
31. Herzer, K., Hofmann, T., Teufel, A., Schimanski, C., Moehler, M., Kanzler, S., Schulze-Bergkamen, H. and Galle, P., IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53. Cancer Res. 2009. 69: 855-862.
32. Papageorgiou, A., Dinney, C. and McConkey, D., Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol. Ther. 2007. 6: 872-879.
33. Sleijfer, S., Bannink, M., Van Gool, A., Kruit, W. and Stoter, G., Side effects of interferon-alpha therapy. Pharm. World Sci. 2005. 27: 423-431.
34. Ronnblom, L., Alm, G. and Eloranta, M., Type I interferon and lupus. Curr. Opin. Rheumatol. 2009. 21: 471-477.
35. Sedger, L. M., Glaccum, M. B., Schuh, J. C., Kanaly, S. T., Williamson, E., Kayagaki, N., Yun, T. et al., Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/ Apo2L gene-deficient mice. Eur. J. Immunol. 2002. 32: 2246-2254.
36. Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R. and Berns, A., Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 1991. 19: 4293.
37. Uze, G., Lutfalla, G. and Gresser, I., Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 1990. 60: 225-234.
38. Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P. and Colamonici, O., Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J. Biol. Chem. 1995. 270: 21606-21611.
39. Mizushima, S. and Nagata, S., pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 1990. 18: 5322.
40. Shiraishi, T., Suzuyama, K., Okamoto, H., Mineta, T., Tabuchi, K., Nakayama, K., Shimizu, Y. et al., Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif. Biochem. Biophys. Res. Commun. 2004. 322: 197-202.
41. Rubinstein, S., Familletti, P. and Pestka, S., Convenient assay for interferons. J. Virol. 1981. 37: 755-758.